Ghaemi, S. Nassir
Angst, Jules
Vohringer, Paul A.
Youngstrom, Eric A.
Phelps, James
Mitchell, Philip B.
McIntyre, Roger S.
Bauer, Michael
Vieta, Eduard
Gershon, Samuel
Article History
Received: 15 December 2021
Accepted: 16 June 2022
First Online: 13 October 2022
Declarations
:
: No new human research was conducted for this review and thus informed consent was not required.
: No individual data included.
: Competing interests are received as follows: <i>Dr. Ghaemi</i> was an employee of Novartis Institutes for Biomedical Research in 2017–2021. <i>Dr. McIntyre</i> has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC); speaker/consultation fees from Lundbeck, Janssen, Alkermes,Neumora Therapeutics, Boehringer Ingelheim,Sage,Biogen,Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, Atai Life Sciences. Dr. Roger McIntyre is a CEO of Braxia Scientific Corp. <i>Dr. Vieta</i> has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Angelini, Biogen, Boehringer-Ingelheim, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, GH Research, Glaxo Smith-Kline, Janssen, Lundbeck, Novartis, Otsuka, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris, outside the submitted work. <i>Dr. Youngstrom</i> has received royalties from Guilford Press and the American Psychological Association, and consulted with Signant Health about psychological assessment. He is the co-founder and executive director of Helping Give Away Psychological Science, 501c3 (HGAPS.org). <i>Dr. Mitchell</i> has received remuneration from Janssen (Australia) and Sanofi (Hangzhou) within the last 3 years for advisory board membership or lectures. No competing interests for Drs. Vohringer, Angst, Gershon, Phelps, and Bauer.